Fluperlapine

This classification denotes a serotonin antagonist and dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EWG253M961. European Medicines Agency schedules Fluperlapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07728MIG. Fluperlapine generally arises in the molecular formula C19H20FN3. The term FLUPERLAPINE is an International Non-Proprietary Name or INN. FLUPERLAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluperlapine under HS 29335995 and SITC 51576. As of Q4 2014, FLUPERLAPINE remains the US FDA Preferred Term for this commodity. Fluperlapine bears US NLM identifiers UMLS ID C0060579 and NCI Concept Code C73316. SMILES: FC1CC2N=C(N3CCN(CC3)C)C3C(CC2CC1)CCCC3.